Federal contract award
75N91021P00243
THESE RECOMBINANT DNA ARE REQUIRED FOR THE PRODUCTION OF RECOMBINANT SIV GP120 AND DNA VECTORS FOR VACCINATION OF RHESUS MACAQUES IN AN UPCOMING ANIMAL STUDY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $14.9K |
| Current contract value | $14.9K |
| Potential contract value / ceiling | $14.9K |
| Start date | Feb 9, 2021 |
| Current end date | Mar 8, 2021 |
| Potential end date | Mar 8, 2021 |
| Latest award activity | Jul 17, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 17, 2026 | P00002 | $-1 | TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| May 7, 2026 | P00001 | $-3 | TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Feb 9, 2021 | 0 | $14.9K | THESE RECOMBINANT DNA ARE REQUIRED FOR THE PRODUCTION OF RECOMBINANT SIV GP120 AND DNA VECTORS FOR VACCINATION OF RHESUS MACAQUES IN AN UPCOMING ANIMAL STUDY |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.